| abstract |
The present invention relates to a method for enhancing the absorption of migraine drugs, and an effective amount of ghrelin mimetic or a pharmaceutical thereof to a subject in need of treating migraine by enhancing absorption of migraine drugs. An acceptable salt, hydrate or solvate and at least one migraine agent, wherein the at least one migraine agent is a serotonin 5-HT 1B / 1D receptor agonist, tryptamine derivative, ergoline derivative , Selected from non-steroidal anti-inflammatory or analgesic drugs or any combination thereof). |